MedPath

Total Intravenous Anaesthesia: Comparison of two drug combinations Propofol-Ketamine and Propofol-Dexmedetomidine combinations in Total intravenous anaesthesia to evaluate the induction characteristics, maintenance of anaesthesia and recovery characteristics & Side effects.

Active, not recruiting
Conditions
Patients undergoing sergical procedures PAC fit
Registration Number
CTRI/2018/02/012057
Lead Sponsor
Peoples College of Medical Sciences
Brief Summary

Aim of study  to compare efficacy,safety and  stability of vitals of  two drug combinations I.V. Propofol -Ketamine and Propofol- Dexmedetomedine in Total Intravenous anaesthesia. The study  to compare induction characteristics, maintenance of anaesthesia, recovery characteristics with these combinations. Side effects if any. Total 100 patients between age 20 to 65 yrs belonging to ASA gr I & II of either sex undergoing short surgical procedure are being included for this study.They are divided into two groups of 50 patients each. Group I(PK) received Propofol-Ketamine combination and Group II(PD) received Propofol-Dexmedetomedine combination. Exclusion:-The patients with any drug allergy,allergy to egg or fat, on MAO inhibitors, with H/O liver disease, pregnant females and patients for long duration surgery  not included. All patients receiving 20 mg Omeprazole and 0.25 mg of Alprozolam at 10.00 PM previous night of surgery. l Patients  preloaded with I/V Ringer Lactate solution 15ml/kg body weight. Intraoperative fluid rescusitation  by Ringer Lactate solution  as formula of 4 ml/kg for first 10 kg body weight, 2 ml/kg for next 10 kg and 1ml/kg for remaining body weight.. 50% of this calculated fluid in first hour and remaining in second hour. Monitoring of all the patients for heart rate, SpO2, ECG and NIBP through out the procedure and in post operative period in recovery room. They are requested to inform any symptom in post operative period. In group I induction  with Propofol 1.0 mg/KgBwt and Ketamine 1.0 mg /kgBwt and in group II with I/V Propofol 1.0 mg/KgBwt and Dexmedetomedine 1.0. mcg/kgBwt. The drugs loaded by separate person not involved in study, the observations are noted by separate person not involved in study. The maintenance of anesthesia done with I.V. Propofol 2.0 mg/kgBwt/hr and Ketamine 2.0mg/KgBwt/hr by infusion pump in group I and with I.V. Propofol 2.0mg/kgBwt/hr and Dexmetomedine 0.7 mcg/kgBwt/hr by infusion pump in group II. Vital parameters like heart rate, NIBP, SpO2,ECG  monitored continuously during procedure. The observation  for any symptoms if any during procedure. The recording of vitals during post operative period in recovery room. Patients are requested to inform any symptom arising in this period. The data obtained will be analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 100 adult patients with ASA Gr I-II between age of 18 to 65 years of age willing for participation in study after explanation of study undergoing short surgical procedures will be includd.They will be devided in two groups 1) group will receive Propofol- Ketamine.
  • combination and group 2) will receive Propofol Dexamedetomedine combination.
  • One capsule of Omeprazole 20 mg and one tab of Alprozolam 0.25 mg given at 10.00 PM previous night of procedure.IV fluid Ringer Lactate will be given for fluid resuscitation.
  • Maintenance with Propofol 2.0 mg and Ketamine 2.0 mg per kg per hour in group 1) and with Propofol 2.0 mg and Dexmedetomedine 0.7 mg per kg per hour in gropup 2).
  • The vital parameters will be observed during operative procedure and postoperative period.
  • The patients will be followed up for any symptoms and signs and vitals recorded in recovery room.
Exclusion Criteria
  • Patients who didnot give consent for participation.
  • Patients with H/O allergy to any particular drug, allergy to egg or fat, on MAO inhibitors, H/O Liver disorder like jaundice etc.
  • Pregnant woman and patients for long surgeries not included in study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Parameters SpO2, NIBP, ECG and heart rate monitored at interval of 5 min for initial 15 min and then every 10 min interval till end. Patients in both groups were ventilated with 100% Oxygen through circuit attached to circle absorber.Side effects if any with the combinations. Change in vital parameters during procedures and in immediate post operative period were noted
All patients in both groups were monitored and followed up in post operative period for any symptoms. The vitals were recorded at 15 min interval in recovery room. It was presumed to have some changes in parameters.Side effects if any with the combinations. Change in vital parameters during procedures and in immediate post operative period were noted
Secondary Outcome Measures
NameTimeMethod
There was slight increase in pulse rate in both groups,insignificant change in Blood Pressure,time of drowsiness was more in Ketamine group,nausea and vomiting were comparable in bothThere was slight increase in pulse rate in both groups which persisted for brief period of 35 min.,insignificant change in Blood Pressure,time of drowsiness was more in Ketamine group in recovery period, nausea and vomiting were comparable in both

Trial Locations

Locations (1)

Peoples College of Medical Sciences

🇮🇳

Bhopal, MADHYA PRADESH, India

Peoples College of Medical Sciences
🇮🇳Bhopal, MADHYA PRADESH, India
Dr Kanhaiya Lal Kishnani
Principal investigator
07554004010
drkishnani@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.